Filtern
Volltext vorhanden
- ja (5)
Gehört zur Bibliographie
- ja (5)
Dokumenttyp
Schlagworte
- SARS-CoV-2 (3)
- Genetik (1)
- Kraniosynostose (1)
- Mikroarray basierte vergleichende Genomhybridisierung (Array-CGH) (1)
- Next Generation Sequencing (NGS) (1)
- acetylsalicylic acid (1)
- acid sphingomyelinase (1)
- anthocyanin (1)
- antiviral activity (1)
- aspirin (1)
- astaxanthin (1)
- azapeptide nitriles (1)
- bilberry (1)
- black currant (1)
- cell line specificity pyridyl indole carboxylates (1)
- ceramidase (1)
- ceramides (1)
- fluoxetine (1)
- herpesvirus (1)
- measels virus (1)
- peptidomimetics (1)
- precision-cut lung slices (1)
- protease inhibitors (1)
- salicylic acid (1)
Recently, we have described novel pyridyl indole esters and peptidomimetics as potent inhibitors of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) main protease. Here, we analysed the impact of these compounds on viral replication. It has been shown that some antivirals against SARS-CoV-2 act in a cell line-specific way. Thus, the compounds were tested in Vero, Huh-7, and Calu-3 cells. We showed that the protease inhibitors at 30 µM suppress viral replication by up to 5 orders of magnitude in Huh-7 cells, while in Calu-3 cells, suppression by 2 orders of magnitude was achieved. Three pyridin-3-yl indole-carboxylates inhibited viral replication in all cell lines, indicating that they might repress viral replication in human tissue as well. Thus, we investigated three compounds in human precision-cut lung slices and observed donor-dependent antiviral activity in this patient-near system. Our results provide evidence that even direct-acting antivirals may act in a cell line-specific manner.